Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 11, 2014 07:00 ET | Source: Alcobra Ltd.

Alcobra Announces Second Quarter Financial Results and Provides Corporate Update

Company Describes New Brain Imaging Data Supporting Use of MDX in ADHD Company Reviews Patients Demographics in Phase III study Conference Call & Webcast at 8:30 a.m. Eastern...
August 08, 2014 08:41 ET | Source: Alcobra Ltd.

Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects of MDX

TEL AVIV, Israel, Aug. 8, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
August 06, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Provide Corporate Overview at the Canaccord Genuity 34th Annual Growth Conference

TEL AVIV, Israel, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
August 01, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Second Quarter 2014 Results and Host Investor Conference Call and Webcast on Monday, August 11

TEL AVIV, Israel, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 17, 2014 08:12 ET | Source: Alcobra Ltd.

Alcobra Discusses New Market Research and Updates on Recent Corporate Events at Investor Forum in New York City

TEL AVIV, Israel, July 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 14, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra Completes Patient Recruitment in Phase III Clinical Trial of MDX in Adult ADHD

TEL AVIV, Israel, July 14, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
July 07, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra to Host Investor Forum and Webcast on July 15 in New York City

TEL AVIV, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
June 17, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference

TEL AVIV, Israel, June 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
June 09, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention

TEL AVIV, Israel, June 9, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...
May 27, 2014 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference

TEL AVIV, Israel, May 27, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right